Cyclohexanecarboxylic acid
Cyclohexanecarboxylic acid structure
|
Common Name | Cyclohexanecarboxylic acid | ||
|---|---|---|---|---|
| CAS Number | 98-89-5 | Molecular Weight | 128.169 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 233.0±8.0 °C at 760 mmHg | |
| Molecular Formula | C7H12O2 | Melting Point | 29-31 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 107.0±13.1 °C | |
| Symbol |
GHS05, GHS07 |
Signal Word | Danger | |
|
Synthesis of a red fluorescent dye-conjugated Ag@SiO2 nanocomposite for cell immunofluorescence.
Appl. Spectrosc. 69(2) , 215-21, (2015) In this work we describe a one-step approach for incorporating a red fluorophore (2SBPO) into core-shell nanoparticles for metal-enhanced fluorescence immunolabels. The 2SBPO-MEF nanoparticles are particularly attractive as cell labels because their ∼ 670 nm ... |
|
|
Naphthenic acid biodegradation by the unicellular alga Dunaliella tertiolecta.
Chemosphere 84(4) , 504-11, (2011) Naphthenic acids (NAs) are a major contributor to toxicity in tailings waste generated from bitumen production in the Athabasca Oil Sands region. While investigations have shown that bacteria can biodegrade NAs and reduce tailings toxicity, the potential of a... |
|
|
Simple procedure for determination of valproic acid in dried blood spots by gas chromatography–mass spectrometry
J. Pharm. Biomed. Anal. 96 , 207-12, (2014) Valproic acid (VA) is a drug widely used to treat epilepsy and bipolar disorder, at recommended serum concentrations ranging form 50 to 100μg ml(-1). A novel option for therapeutic drug monitoring that has been emerging recently its testing using dried blood ... |
|
|
A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid.
Bioorg. Med. Chem. 21(1) , 42-61, (2013) We have carried out the optimization of substituents at the C-3 or the C-5 position on the pyrrolidine ring of VLA-4 antagonist 3 with 2-(phenylamino)-7-fluorobenzoxazolyl moiety for the purpose of improving in vivo efficacy while maintaining good aqueous sol... |
|
|
Metabolism of hydroxylated and fluorinated benzoates by Syntrophus aciditrophicus and detection of a fluorodiene metabolite.
Appl. Environ. Microbiol. 75(4) , 998-1004, (2009) Transformations of 2-hydroxybenzoate and fluorobenzoate isomers were investigated in the strictly anaerobic Syntrophus aciditrophicus to gain insight into the initial steps of the metabolism of aromatic acids. 2-Hydroxybenzoate was metabolized to methane and ... |
|
|
Effect of starter unit availability on the spectrum of manumycin-type metabolites produced by Streptomyces nodosus ssp. asukaensis.
J. Appl. Microbiol. 111(5) , 1116-28, (2011) S Pospíšil, K Petříčková, P Sedmera, P Halada, J Olšovská, M Petříček |
|
|
Metabolism of benzoate, cyclohex-1-ene carboxylate, and cyclohexane carboxylate by "Syntrophus aciditrophicus" strain SB in syntrophic association with H(2)-using microorganisms.
Appl. Environ. Microbiol. 67(4) , 1728-38, (2001) The metabolism of benzoate, cyclohex-1-ene carboxylate, and cyclohexane carboxylate by "Syntrophus aciditrophicus" in cocultures with hydrogen-using microorganisms was studied. Cyclohexane carboxylate, cyclohex-1-ene carboxylate, pimelate, and glutarate (or t... |
|
|
Pharmacokinetics and pharmacodynamics of valproate analogs in rats. II. Pharmacokinetics of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid.
Biopharm. Drug Dispos. 14(4) , 325-39, (1993) The pharmacokinetics of valproic acid (VPA) and three structural analogs, octanoic acid (OA), cyclohexanecarboxylic acid (CCA), and 1-methyl-1-cyclohexanecarboxylic acid (MCCA), were examined in female Sprague-Dawley rats. All four carboxylic acids evidenced ... |
|
|
Pharmacokinetics and pharmacodynamics of valproate analogues in rats. IV. Anticonvulsant action and neurotoxicity of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid.
Epilepsia 35(1) , 234-43, (1994) We examined the pharmacodynamics of valproate (VPA) and three structural analogues, octanoic acid (OA), cyclohexanecarboxylic acid (CCA), and 1-methyl-1-cyclohexanecarboxylic acid (MCCA) in rats. A pentylenetetrazol (PTZ) infusion seizure model was used to de... |
|
|
Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat.
Drug Metab. Dispos. 20(6) , 810-5, (1992) The pharmacokinetics of valproic acid (VPA) and its structural analogs cyclohexanecarboxylic acid (CCA) and 1-methyl-1-cyclohexanecarboxylic acid (MCCA) were examined in bile-exteriorized rats. A 0.52 mmol/kg dose (equivalent to 75 mg/kg VPA) of test compound... |